Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Highly Accessed Research article

Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study

Heather Greenlee12*, Marilyn L Kwan3, Isaac J Ergas3, Garrett Strizich1, Janise M Roh3, Allegra T Wilson3, Marion Lee4, Karen J Sherman5, Christine B Ambrosone6, Dawn L Hershman127, Alfred I Neugut127 and Lawrence H Kushi3

Author Affiliations

1 Mailman School of Public Health, Columbia University, New York, NY 10032, USA

2 Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10032, USA

3 Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA

4 University of California San Francisco, San Francisco, CA 94143, USA

5 Group Health Research Institute, Seattle, WA 98101, USA

6 Roswell Park Cancer Institute, Buffalo, NY 14263, USA

7 College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA

For all author emails, please log on.

BMC Cancer 2014, 14:382  doi:10.1186/1471-2407-14-382

Published: 29 May 2014



Vitamin and mineral supplement use after a breast cancer diagnosis is common and controversial. Dosages used and the timing of initiation and/or discontinuation of supplements have not been clearly described.


We prospectively examined changes in use of 17 vitamin/mineral supplements in the first six months following breast cancer diagnosis among 2,596 members (28% non-white) of Kaiser Permanente Northern California. We used multivariable logistic regression to examine demographic, clinical, and lifestyle predictors of initiation and discontinuation.


Most women used vitamin/mineral supplements before (84%) and after (82%) diagnosis, with average doses far in excess of Institute of Medicine reference intakes. Over half (60.2%) reported initiating a vitamin/mineral following diagnosis, 46.3% discontinuing a vitamin/mineral, 65.6% using a vitamin/mineral continuously, and only 7.2% not using any vitamin/mineral supplement before or after diagnosis. The most commonly initiated supplements were calcium (38.2%), vitamin D (32.01%), vitamin B6 (12.3%) and magnesium (11.31%); the most commonly discontinued supplements were multivitamins (17.14%), vitamin C (15.97%) and vitamin E (45.62%). Higher education, higher intake of fruits/vegetables, and receipt of chemotherapy were associated with initiation (p-values <0.05). Younger age and breast-conserving surgery were associated with discontinuation (p-values <0.05).


In this large cohort of ethnically diverse breast cancer patients, high numbers of women used vitamin/mineral supplements in the 6 months following breast cancer diagnosis, often at high doses and in combination with other supplements. The immediate period after diagnosis is a critical time for clinicians to counsel women on supplement use.

Breast cancer; Cohort studies; Vitamins; Multivitamins; Dietary supplements